NET PROFIT (x1000 EUR)
EMPLOYEES
Lokon Pharma AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-6,522
|
-6,644
|
-4,527 |
| EBITDA |
-6,520
|
-6,643
|
-4,525 |
| Total assets |
1,326
|
1,380
|
1,394 |
| Current assets |
1,322
|
1,375
|
1,387 |
| Current liabilities |
1,275
|
1,298
|
1,316 |
| Equity capital |
50
|
82
|
79 |
| - share capital |
4
|
5
|
5 |
| Employees (average) |
8
|
7
|
7 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
3.8%
|
5.9%
|
5.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-491.9%
|
-481.4%
|
-324.7% |
| Current ratio |
103.7%
|
105.9%
|
105.4% |
| Return on equity (ROE) |
-13044.0%
|
-8102.4%
|
-5730.4% |
| Change turnover |
0
|
0
|
-30 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
1
|
0
|
4 |
| Chg. No. of employees % |
14%
|
0%
|
133% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.